Cargando…
Neonate Intestinal Immune Response to CpG Oligodeoxynucleotide Stimulation
BACKGROUND: The development of mucosal vaccines is crucial to efficiently control infectious agents for which mucosae are the primary site of entry. Major drawbacks of these protective strategies are the lack of effective mucosal adjuvant. Synthetic oligodeoxynucleotides that contain several unmethy...
Autores principales: | Lacroix-Lamandé, Sonia, Rochereau, Nicolas, Mancassola, Roselyne, Barrier, Mathieu, Clauzon, Amandine, Laurent, Fabrice |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788271/ https://www.ncbi.nlm.nih.gov/pubmed/20011519 http://dx.doi.org/10.1371/journal.pone.0008291 |
Ejemplares similares
-
Mesenteric lymph node cells from neonates present a prominent IL-12 response to CpG oligodeoxynucleotide via an IL-15 feedback loop of amplification
por: Ferret-Bernard, Stéphanie, et al.
Publicado: (2011) -
CpG oligodeoxynucleotides as mucosal adjuvants
por: Iho, Sumiko, et al.
Publicado: (2015) -
Cooperative Stimulation of Dendritic Cells by Cryptococcus neoformans Mannoproteins and CpG Oligodeoxynucleotides
por: Dan, Jennifer M., et al.
Publicado: (2008) -
CpG-Oligodeoxynucleotide Treatment Protects against Ionizing Radiation-Induced Intestine Injury
por: Zhang, Chao, et al.
Publicado: (2013) -
CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis
por: Hurtado, Plinio R, et al.
Publicado: (2008)